IN8BIO, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that IN8BIO, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($3.85M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($5.09M) | Aug 7, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($5.09M) | Nov 6, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($5.55M) | Aug 7, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($5.55M) | Nov 6, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($5.55M) | May 7, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($7.09M) | Nov 6, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($8.63M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($8.63M) | Aug 7, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($8.56M) | Nov 6, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($8.56M) | May 7, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($8.56M) | Aug 7, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($7.17M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($7.72M) | Aug 8, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($7.72M) | Nov 12, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($7.53M) | Nov 12, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($7.53M) | May 9, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($7.53M) | Aug 8, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($7.40M) | Nov 9, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($7.18M) | Aug 10, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($3.85M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($5.09M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($5.55M) | May 7, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($7.09M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($8.63M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($8.56M) | May 7, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($7.17M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($7.72M) | Aug 8, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($7.53M) | May 9, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($7.40M) | Nov 9, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($7.18M) | Aug 10, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($6.15M) | May 12, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($3.39M) | Nov 10, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($3.05M) | Aug 12, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($2.36M) | May 12, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($1.68M) | Nov 10, 2021 |
| Q2 | 2021 | Jun 30, 2020 | ($2.87M) | Sep 10, 2021 |